Sharma East India Hosp and Medical Research Share Price Live
Live Sharma East India Hosp and Medical Research Share Price Chart
Sharma East India Hosp and Medical Research Performance
Days Range
| Previous Close | ₹129.90 |
|---|---|
| Open | ₹120.2 |
| Volume | 235 |
| Day's Range | ₹120.20 - ₹134.50 |
|---|---|
| 52W Range | ₹59.51 - ₹233.90 |
| Market Cap | ₹42.61 Cr |
Sharma East India Hosp and Medical Research Fundamentals
| ROCE(TTM) | 10.99 |
|---|---|
| P/E Ratio (TTM) | 33.05 |
| P/B Ratio | 3.48 |
| Industry P/E | 78.89 |
| Debt to Equity | 0.4 |
| ROE | 9.84 |
| EPS (TTM) | 3.93 |
| Dividend Yield | 0 |
| Book Value | 37.30 |
| Face Value | 10 |
| ROCE(TTM) | 10.99 |
|---|---|
| P/E Ratio (TTM) | 33.05 |
| P/B Ratio | 3.48 |
| Industry P/E | 78.89 |
| Debt to Equity | 0.4 |
| ROE | 9.84 |
|---|---|
| EPS (TTM) | 3.93 |
| Dividend Yield | 0 |
| Book Value | 37.30 |
| Face Value | 10 |
Sharma East India Hosp and Medical Research Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 8.15 | 5.98 | 9.47 | 9.38 |
| Expenses | 7.65 | 5.85 | 8.97 | 8.88 |
| Profit before tax | 0.39 | 0.23 | 0.43 | 0.46 |
| Operating Profit | 0.29 | 0.37 | 0.32 | 0.32 |
| Net Profit | 0.29 | 0.37 | 0.32 | 0.32 |
| ESP in Rs | 0.88 | 1.12 | 0.97 | 0.97 |
Sharma East India Hosp and Medical Research Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0% | 0% | 0% | 0% | 0% |
| Public | 46.37% | 46.37% | 46.37% | 46.37% | 46.37% |
About Sharma East India Hosp and Medical Research
Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989. The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989.
As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India. It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery. NABH accreditation is a scarce jewel for the Company. Performance of the organization against the stated mission is achieved by the increase in number of patients.
The Company has launched the S-ROM Modular Hip System, the most advanced artificial hip implant designed to reduce stiffness and thigh pain. The hospital is providing the service of Heart Surgery. The hospital is also providing the service of Replacement surgery through the use of new and advance implant.
The Company is first in the state of Rajasthan which performed 'Replacement Surgery'. The specially designed state of the art operation theatre is first of its kind in Rajasthan. This theatre has total body exhaust system and 'Antistatic' flooring which makes it totally sterile. That's why, Company became successful in getting reorganization from many reputed Govt. Bodies/Corporations/Banks and other private enterprises for reimbursement of medical claims of their employees being treated at the hospital.
Parent Organisation
Indian Private
Managing Director
None
Founded
1989
NSE Symbol
Top Mutual Funds Invested in Sharma East India Hosp And Medical Research Share
Top Mutual Funds Invested in Sharma East India Hosp And Medical Research Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Max Healthcare Institute Ltd | 1,082.0 4.90 (0.45%) | ₹1,04,747.80 | 940.05 - 1,314.3![]() |
| Apollo Hospitals Enterprise Ltd | 7,007.0 -11.50 (-0.16%) | ₹1,00,923.89 | 6,001.0 - 8,099.5![]() |
| Fortis Healthcare Ltd | 855.5 2.55 (0.30%) | ₹64,397.93 | 577.0 - 1,104.3![]() |
| Narayana Hrudayalaya Ltd | 1,881.9 24.30 (1.31%) | ₹37,969.22 | 1,256.55 - 2,370.2![]() |
| Aster DM Healthcare Ltd | 616.5 -13.30 (-2.11%) | ₹32,654.58 | 387.1 - 732.2![]() |
| Global Health Ltd | 1,147.7 -9.30 (-0.80%) | ₹31,113.83 | 996.45 - 1,456.5![]() |
Popular stocks
Sharma East India Hosp And Medical Research Ltd FAQs
What is the share price of Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares?
Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) share price as of December 11, 2025, on NSE is Rs 134.4 (NSE) and Rs 134.4 (BSE) on BSE.
Can I buy Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) from Angel One?
Yes, You can buy Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares by opening a Demat account with Angel One.
How do I buy Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) from Angel One?
Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares.
1. Direct investment: You can buy Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sharma East India Hosp And Medical Research Ltd (Sharma East India Hosp And Medical Research Ltd) shares.




